J&J taps kidney specialist Vifor for Invokana marketing help

4th November 2019 Uncategorised 0

Johnson & Johnson scored a one-of-a-kind win for SGLT2 med Invokana in September with an FDA approval to treat kidney disease. Now, as a newcomer to the field, J&J is seeking an experienced hand to help sell its flagging med. The company has brought on Vifor Pharma to market Invokana U.S. nephrologists.

More: J&J taps kidney specialist Vifor for Invokana marketing help
Source: fierce